Patents-Review.com
ClassID:

96810 ⎘

C07K14/18 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; RNA viruses Togaviridae; Flaviviridae

Sub-classes:
Recent Application in this class:
#1
20260062469
2026-03-05

COMPOSITIONS AND METHODS FOR LINEAR AND CONFORMATIONAL SITE-SPECIFIC ANTIBODIES AND METHODS OF MAKING THE SAME

 #2
20250018023
2025-01-16

Zika Virus Vaccine

 #3
20240226291
2024-07-11

COMBINATION OF NOVEL VACCINES AGAINST ZIKA VIRUS AND DNA ANTIBODY CONSTRUCTS FOR USE AGAINST ZIKA VIRUS

 #4
20240131154
2024-04-25

COMBINATION OF NOVEL VACCINES AGAINST ZIKA VIRUS AND DNA ANTIBODY CONSTRUCTS FOR USE AGAINST ZIKA VIRUS

 #5
20240108712
2024-04-04

Zika virus vaccine

 #6
20240058438
2024-02-22

Hepatitis C virus immunogenic compositions and methods of use thereof

 #7
20230226165
2023-07-20

Zika virus vaccine

 #8
20230212271
2023-07-06

COMPOSITIONS AND METHODS FOR LINEAR AND CONFORMATIONAL SITE-SPECIFIC ANTIBODIES AND METHODS OF MAKING THE SAME

 #9
20230056142
2023-02-23

Virus purification

 #10
20220354942
2022-11-10

Attenuating viral mutations in protein genes

 #11
20220273786
2022-09-01

Zika virus vaccine

 #12
20210388409
2021-12-16

PPROCESS FOR PRODUCING A RECOMBINANT FRAGMENT OF THE C-TERMINAL REGION OF THE FLAVIVIRUS NONSTRUCTURAL SOLUBLE PROTEIN NS1, PURIFICATION PROCESS, PRODUCT, USE OF THE PRODUCT, METHOD OF DETECTION AND METHOD OF DIAGNOSIS

 #13
20210355200
2021-11-18

Antibody Molecules and Peptide Delivery Systems for Use in Alzheimer's Disease and Related Disorders

 #14
20210170018
2021-06-10

Hepatitis C virus immunogenic compositions and methods of use thereof

 #15
20210093707
2021-04-01

Zika virus purification

 #16
20200384099
2020-12-10

Zika virus vaccine

 #17
20200368342
2020-11-26

Virus purification

 #18
20200197506
2020-06-25

Virus purification

 #19
20200017555
2020-01-16

ZIKA VIRUS VACCINE

 #20
20190276500
2019-09-12

Heterologous expression cassette, DNA construct and vaccine composition to immunize against flavivirus and/or other pathogens

 #21
20190231867
2019-08-01

Hepatitis C virus immunogenic compositions and methods of use thereof

 #22
20190209674
2019-07-11

DNA antibody constructs encoding anti-ZIKV envelope antibodies

 #23
20190008945
2019-01-10

Zika virus purification

 #24
20180371027
2018-12-27

Zika virus vaccine

 #25
20180369359
2018-12-27

Virus purification

 #26
20180362937
2018-12-20

Virus purification

 #27
20180362936
2018-12-20

Zika virus purification

 #28
20180009883
2018-01-11

Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders

 #29
20180008690
2018-01-11

Nanocapsules carrying chikungunya-associated peptides

 #30
20160367658
2016-12-22

Avirulent, immunogenic flavivirus chimeras

 #31
20120014981
2012-01-19

Avirulent, immunogenic flavivirus chimeras

 #32
20110124123
2011-05-26

Method for examining WT1-related disease

 #33
20100255030
2010-10-07

Avirulent, immunogenic flavivirus chimeras

 #34
20090010961
2009-01-08

Avirulent, immunogenic flavivirus chimeras

 #35
20060062803
2006-03-23

Avirulent, immunogenic flavivirus chimeras

 #36
20050148037
2005-07-07

Method for examining WT1-related disease